Clinical Trial

Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 14, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This research will employ cross-sectional analytical to determine diagnostic accuracy of Flourodeoxyglucose-18 Positron Emission Computed Tomography in the evaluation of Recurrent Papillary Thyroid Carcinoma with patient's raised Thyroglobulin level in Lahore.
Trial Details
NCT Number NCT07062211
Lead Sponsor Superior University
Conditions Papillary Thyroid Carcinoma
Enrollment 39 participants
Start Date 2025-03-17
Primary Completion 2025-09-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-14